With an initial seed investment of $12 million, Optain becomes the first company announced in Ascertain's growing portfolio of AI companies.
The two companies are expanding their strategic collaboration with the integration of Azure OpenAI Service
Users of Ascensia's world-renowned CONTOUR BGM portfolio will now be able to seamlessly incorporate SNAQ into their diabetes management regimen
The relationship will give consumers lower-cost medications and diabetes testing supplies and more personalized, higher-quality care
Effective immediately, MediOrbis clients can use this tool as a means of providing patient information, streamlining telehealth visits, engaging patients and assisting providers.
Prescryptive Health, Lilly partner on first-to-market value-based program to stabilize insulin pricing
The new financial model aims to provide price transparency while encouraging medication adherence.
Boehringer Ingelheim, Click Therapeutics expand their collaboration to develop digital therapeutics for schizophrenia
The partnership aims to provide additional treatment options to those living with schizophrenia, where there remains a significant unmet need...
The two companies initiate research agreement supporting development of new AI-ECG algorithm to help identify patients who may be at risk of cardiac amyloidosis
Leveraging care.ai's technology, the program will streamline clinical workflows to support an overburdened nursing workforce and improve patient care and experience
The program is designed to improve patient healthcare outcomes by integrating genetic insights into clinical care and research.